Additionally, the implementation of genetic testing to identify genes associated with malformations (ZFYVE9, TIMP1, PRKX, KDM6A) can lead to a higher detection rate of aortic aneurysm formation, congenital urinary malformations and other anomalies (51). This evidence concerns the gene PRKX and aortic aneurysm.